The leading source for credible citizen reporting

Report Your News
Take the tour...

This event is older than two months and is no longer active. Some links older than two months could be broken.

Report Your News

Click here to post a new related report

Study: Prostate cancer drug boosts heart disease odds

London : United Kingdom | 2 months ago  
Views: 0
AstraZeneca Plc's Zoladex and other prostate cancer treatments used to block the hormones that fuel tumor growth in men with advanced forms of the illness may leave them more prone to heart disease, a new study found. The results, presented at the European Cancer Organization and European Society...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: NewKerala | 2 months ago
    It involves either removing the testicles to eliminate the main source of testosterone production. The researchers suggest that doctors need to start considering heart-related side effects when they prescribe endocrine therapy for prostate cancer and...
  • News Source: Houston Chronicle | 2 months ago
    AstraZeneca Plc's Zoladex and other prostate cancer treatments used to block the hormones that fuel tumor growth in men with advanced forms of the illness may leave them more prone to heart disease, a new study found. The results, presented at the...
  • News Source: Star Tribune | 2 months ago
    A common treatment for prostate cancer may slightly increase patients' risk of heart problems, new research says. Experts said the findings could make doctors think twice before prescribing the standard hormone treatment to men with prostate cancer,...
Most Popular Reports

Related Allvoices Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.